Efficacy of Lacosamide and Rufinamide as Adjuncts to Midazolam-Ketamine Treatment Against Cholinergic-Induced Status Epilepticus in Rats-Reference-Cited by-同舟云学术

Efficacy of Lacosamide and Rufinamide as Adjuncts to Midazolam-Ketamine Treatment Against Cholinergic-Induced Status Epilepticus in Rats

Published:2023-11-17 Issue:2 Volume:388 Page:347-357
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Lumley Lucille A.^ORCID,Nguyen Donna A.,de Araujo Furtado Marcio,Niquet Jerome^ORCID,Linz Emily O.,Schultz Caroline R.^ORCID,Stone Michael F.,Wasterlain Claude G.^ORCID

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. Novel antiepileptic drug lacosamide exerts neuroprotective effects by decreasing glial activation in the hippocampus of a gerbil model of ischemic stroke

2. Rufinamide

3. Lacosamide: A Review of Preclinical Properties

4. Clinical pharmacokinetic and pharmacodynamic profile of lacosamide;Cawello;Clin Pharmacokinet,2015

5. Post-Treatment with Voltage-Gated Na+ Channel Blocker Attenuates Kainic Acid-Induced Apoptosis in Rat Primary Hippocampal Neurons

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Special Section on Medical Countermeasures, From Bench to Battlefield: Translating Experimental Therapies for Effective Combat Against Chemical Threats–Editorial;Journal of Pharmacology and Experimental Therapeutics;2024-01-17

2. Progress and Challenges in Developing Medical Countermeasures for Chemical, Biological, Radiological, and Nuclear Threat Agents;Journal of Pharmacology and Experimental Therapeutics;2024-01-17